The role of radiotherapy in the management of operable locally advanced breast carcinoma: Results of a randomized trial by the Eastern Cooperative Oncology Group

Cancer

Volumn 79, Issue 6, 1997, Pages 1138-1149

  Olson, John E ^a   Neuberg, Donna ^b   Pandya, Kishan J ^c   Richter, Melvyn P ^d   Solin, Lawrence J ^d   Gilchrist, Kennedy W ^e   Tormey, Douglass C ^f   Veeder, Michael ^g   Falkson, Geoffrey ^h  

^a BASSETT MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNITY HEALTH SYSTEM   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF WISCONSIN   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g Illinois Oncol Res Assoc CCOP   (United States)

^h UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

locally advanced breast carcinoma; radiotherapy; surgery; systemic therapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FLUOXYMESTERONE; METHOTREXATE; TAMOXIFEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; FLUOXYMESTERONE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; RECURRENCE; SURVIVAL ANALYSIS; TAMOXIFEN;

EID: 0030993557     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970315)79:6<1138::AID-CNCR12>3.0.CO;2-0     Document Type: Article

References (35)

1. Haagensen CD, Stout AP. Carcinoma of the breast: criteria of operability. Ann Surg 1943;118:859-70, 1032-51.
2. Haagensen CD. Diseases of the breast. 3rd edition. Philadelphia, London, Toronto: WB Saunders, 1986:851-63.
3. Zucali R, Uslenghi C, Kendra R, Bonadonna G. Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy. Cancer 1976;37:1422-31.
4. Sorace RA, Lippman ME. Locally advanced breast cancer. In: Lippman ME, Lichter AS, Danforth DN, editors. Diagnosis and management of breast cancer. Philadelphia, London, Toronto: WB Saunders, 1988:272-95.
5. Montague ED. Radiation management of advanced breast cancer. Int J Radiat Oncol Biol Phys 1978;4:305-7.
6. Bruckman JE, Harris JR, Levene MB, Chaffy JT, Hellman S. Results of treating stage III carcinoma of the breast by primary radiation therapy. Cancer 1979;49:985-93.
7. DeLena M, Zucali R, Viganotti G, Valagussa P, Bonadonna G. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmacol 1978;1:53-9.
8. Buzdar AU, Gutterman JU, Blumenschein GR, Hortobagyi GN, Tashima CK, Smith TL, et al. Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer. Cancer 1978;41:1064-75.
9. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
10. Carbone PP, Sears ME. Report from the Combined Modality Trials Working Group in Breast Cancer. Suggested protocol guidelines for combination chemotherapy trials and for combined modality trials. DHEW publication no. (NIH) 77-1192. Washington, DC: Department of Health and Human Services, 1977.
11. Cox DR. Analysis of binary data. London: Methuen, 1970.
12. Peto R, Peto J. Asymptotically efficient rank invariant test procedures (with discussion). J Roy Star Soc A 1972;135:185-206.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1959;53:457-81.
14. Cox DR. Regression models and life tables. J Roy Stat Soc B 1972;34:181-220.
15. Olson JE, Neuberg D, Pandya KJ, Richter MP, Gilchrist KW, Falkson G. The role of radiotherapy in the management of operable locally advanced breast cancer: five year results of the ECOG trial [abstract 201]. Breast Cancer Res Treat 1993;27:181.
16. Donegan WL, Perez-Mesa CM, Watson FR. A biostatistical study of locally recurrent breast cancer. Surg Gynecol Obstet 1966;122:529-40.
17. Haagensen CD, Bodian C. A personal experience with radical mastectomy. Ann Surg 1984;199:143-50.
18. Crowe JP, Gordon NH, Antunez AR, Shenk R, Hubay CA, Shuck JM, et al. Local-regional breast cancer recurrence following mastectomy. Arch Surg 1991;126:429-32.
19. Kennedy MJ, Abeloff MD. Management of locally recurrent breast cancer. Cancer 1993;71:2395-409.
20. Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B. Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 1992;23:285-91.
21. Cuzick J, Stewart H, Rutquist, Houghton J, Edwards R, Redmond C, et al. Cause specific mortality in long-term survivors of breast cancer who participated in trials in radiotherapy. J Clin Oncol 1994;12:447-53.
22. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. NEJM 1995;333:1444-55.
23. Houghton J, Baum M, Haybittle JL. Role of radiotherapy following total mastectomy in patients with early breast cancer. World J Surg 1994;18:117-22.
24. Fisher B, Fisher ER, Redmond C. Ten year results from the NSABP clinical trial evaluating the use of 1-phenylalanine mustard (L-PAM) in the management of primary breast cancer. J Clin Oncol 1986;4:929-41.
25. Goldhirsch A, Gelber RD, Price KN, Castiglione M, Coates AS, Rudenstam CM, et al. Effect of systemic adjuvant treatment on first sites of breast cancer relapse. Lancet 1994;343:377-81.
26. Peters WP, Ross M, Vredenburgh JI, Meisenberg B, Marks LB, Winer E, et al. High dose chemotherapy and autologous bone marrow support as consolidation after standard dose adjuvant therapy for high risk primary breast cancer. J Clin Oncol 1993;11:1132-43.
27. Ragaz J, Jackson SM, Plenderleith IH, Wilson K, Basco V, Knowling M, et al. Can adjuvant radiotherapy improve the overall survival of breast cancer patients in the presence of adjuvant chemotherapy? 10 year analysis of the British Columbia randomized trial [abstract 40]. Proc Am Soc Clin Oncol 1993;12:60.
28. Donegan WL, Stine SB, Samter TG. Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer 1993;72:778-82.
29. Overgaard M, Christensen JJ, Johansen H, Nybo-Rasmussen A, Rose C, van der Kooy P, et al. Evaluation of radiotherapy in high risk cancer patients: report from the Danish Breast Cancer Cooperative Group trial. Int J Radiat Oncol Biol Phys 1990;19:1121-4.
30. Dewar JA, Sarrazin D, Benhamou E, Petit JY, Benhamou S, Arriagada R, et al. Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institut Gustav-Roussy. Int J Radiat Oncol Biol Phys 1987;13:475-81.
31. Fowble B, Gray R, Gilchrist K, Goodman RL, Taylor S, Tormey DC, et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from post-operative radiotherapy. J Clin Oncol 1988;6:1107-17.
32. Schwaibold F, Fowble B, Solin LJ, Schultz D, Goodman RL. The results of radiation therapy for isolated local regional recurrence after mastectomy. Int J Radiat Oncol Biol Phys 1991;21:299-310.
33. Tennvall-Nittby, Tengrup I, Landberg T. The total incidence of locoregional recurrence in a randomized trial of breast cancer TNM Stage II. The South Sweden Breast Cancer Trial. Acta Oncol 1993;32:641-6.
34. Hortobagyi GN. Multidisciplinary management of advanced primary and metastatic breast cancer. Cancer 1994;74:416-23.
35. Schwartz GF, Birchansky CA, Komarnicky LT, Mansfield CM, Cantor RI, Biermann WA, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 1994;73:362-9.